NaCl enhances CD8 + T cell effector functions in cancer immunotherapy
Caterina Scirgolea,Rosa Sottile,Marco De Luca,Alberto Susana,Silvia Carnevale,Simone Puccio,Valentina Ferrari,Veronica Lise,Giorgia Contarini,Alice Scarpa,Eloise Scamardella,Simona Feno,Chiara Camisaschi,Gabriele De Simone,Gianluca Basso,Desiree Giuliano,Emilia Maria Cristina Mazza,Luca Gattinoni,Rahul Roychoudhuri,Emanuele Voulaz,Diletta Di Mitri,Matteo Simonelli,Agnese Losurdo,Davide Pozzi,Carlson Tsui,Axel Kallies,Sara Timo,Giuseppe Martano,Elettra Barberis,Marcello Manfredi,Maria Rescigno,Sebastien Jaillon,Enrico Lugli
DOI: https://doi.org/10.1038/s41590-024-01923-9
IF: 30.5
2024-08-30
Nature Immunology
Abstract:CD8 + T cells control tumors but inevitably become dysfunctional in the tumor microenvironment. Here, we show that sodium chloride (NaCl) counteracts T cell dysfunction to promote cancer regression. NaCl supplementation during CD8 + T cell culture induced effector differentiation, IFN-γ production and cytotoxicity while maintaining the gene networks responsible for stem-like plasticity. Accordingly, adoptive transfer of tumor-specific T cells resulted in superior anti-tumor immunity in a humanized mouse model. In mice, a high-salt diet reduced the growth of experimental tumors in a CD8 + T cell-dependent manner by inhibiting terminal differentiation and enhancing the effector potency of CD8 + T cells. Mechanistically, NaCl enhanced glutamine consumption, which was critical for transcriptional, epigenetic and functional reprogramming. In humans, CD8 + T cells undergoing antigen recognition in tumors and predicting favorable responses to checkpoint blockade immunotherapy resembled those induced by NaCl. Thus, NaCl metabolism is a regulator of CD8 + T cell effector function, with potential implications for cancer immunotherapy.
immunology